跳至主要内容
临床试验/JPRN-UMIN000015547
JPRN-UMIN000015547已完成未知

Study of the effects of febuxostat in patients with diabetic nephropathy. - Study of the effects of febuxostat in patients with diabetic nephropathy.

Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine0 个研究点目标入组 50 人开始时间: 2014年10月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients with a history of hypersensitivity to febuxostat 2)Patients with secondary hyperuricemia 3)Systolic blood pressure 160 mmHg or higher, or diastolic blood pressure 100 mmHg or more 4)AST or ALT levels are more than double of the normal range 5)Patients who have the following disease were excluded. Non- diabetic chronic kidney disease: glomerulonephritis , renal sclerosis , polycystic kidney disease , inflammatory disease or infection, malignant tumor 6)Patients who develop coronary artery disease , cerebrovascular disease within six months 7)Patients who are administered mercaptopurine hydrate (Roikerin), azathioprine (Imran Azanin) 8)Alcoholics(2 Go / day or more sake in a week average) 9)Patients in Breast-feeding or pregnancy 10)Patients judged by the investigator to be ineligible for some other reason

研究者

发起方
Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine

相似试验